Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research

Contract Research

Akashi Therapeutics acquires global rights to GsMTx-4 compound By PBR Staff Writer
Clinical stage biopharmaceutical company Akashi Therapeutics has received global rights to GsMTx-4, a peptide developed by Tonus Therapeutics to address calcium level imbalance in muscle.
Contract Research & Services > Contract Research > News
MedGenesis, Pfizer partner on Parkinson's disease treatments By PBR Staff Writer
MedGenesis Therapeutix has signed an agreement with Pfizer to aid in the development of potential treatments for Parkinson's disease.
Contract Research & Services > Contract Research > News HYD Pharma successfully completes research phase of new cancer drug By PBR Staff Writer
Hungarian pharmaceutical firm HYD Pharma has successfully completed a $1.02m research phase involving the development of a new drug to treat cancer.
Contract Research & Services > Contract Research > News
See more Contract Research news

Latest Contract Research News and Insight

View all Contract Research news or find news targeted to your interests
EMD Serono, Accelerated Cure Project to optimize treatment and understand progression of multiple sclerosis
EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany and the Accelerated Cure Project for Multiple Sclerosis today announced a lead founding sponsor agreement to help launch the Optimizing Treatment-Understanding Progression (OPT-UP) study.
Contract Research & Services > Contract Research > News
GSK joins with research councils in UK and South Africa to tackle non-communicable diseases in Africa
GSK has announced a £5m collaboration with the UK and South African Medical Research Councils, to support much-needed research into non-communicable diseases (NCDs) in Africa, as part of GSK’s Africa NCD Open Lab initiative.
Contract Research & Services > Contract Research > News
Sutro Biopharma to collaborate with University of California as part of Recombinant Antibody Network
Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates and bispecific antibodies, announced its collaboration with the laboratory of James Wells, Ph.D., professor and chair of the Department of Pharmaceutical Chemistry at UCSF, as part of the Recombinant Antibody Network (RAN), an international consortium of three expert centers at the University of Chicago, University of Toronto and UCSF funded by the National Institutes of Health (NIH).
Contract Research & Services > Contract Research > News
PRA Health Sciences Files for Initial Public Offering
PRA Health Sciences, Inc. announced today that it has filed a registration statement on Form S-1 with the US Securities and Exchange Commission (SEC) relating to a proposed initial public offering ('IPO') of shares of its common stock by PRA Health Sciences and an affiliate of Kohlberg Kravis Roberts & Co. L.P. (the 'selling stockholder'). The number of shares to be offered and the price range has not yet been determined.
Contract Research & Services > Contract Research > Press Releases
PRA Health Sciences Expands in Pennsylvania
Blue Bell, Pennsylvania will soon be home to PRA Health Sciences' largest office worldwide. PRA, a leading global contract research organisation (CRO), is relocating employees from its Horsham and Fort Washington locations into new modern class A+ office space in Blue Bell. The new office marks the first phase of the relocation plan.
Contract Research & Services > Contract Research > Press Releases
Pharmaceutical Product Development, Inc.
Pharmaceutical Product Development, Inc (PPD) is a global leading contract research organization that provides drug discovery, development and lifecycle management services to its customers. Its drug development services comprise preclinical drug discovery services, programs, Phase I through Phase IV clinical development services and post-approval services, and bioanalytical good manufacturing practices (cGMP), global central laboratory and vaccines and biologics laboratory services. The company provides clinical trial expertise across a wide range of therapeutic areas to over 100 countries, spanning across six continents. In addition, PPD offers support for marketed drugs, biologics and devices, with medical information, patient compliance programs, product safety and pharmacovigilance, patient and disease registry programs, observational studies, standard response document development, Phase IV monitored studies and prescription to over-the-counter programs. The company operates under two business segments, Clinical Development Services and Laboratory Services. It owns and operates 86 offices across 43 countries worldwide. The company’s partners and clients include biotechnology, pharmaceutical, medical device, academic, government and non-profit organizations. PPD is headquartered in Wilmington, North Carolina, the US.
Contract Research & Services > Contract Research > Companies
Pharmatech enters into research collaboration with Weill Cornell Medical College
Pharmatech, Weill Cornell Medical College (WCMC) and 25 other leading oncology practices have agreed to evaluate an innovative program for rapidly identifying and enrolling patients in oncology clinical trials, sponsored by the Small Business Innovative Research (SBIR) grant funded by the National Cancer Institute (NCI).
Contract Research & Services > Contract Research > News
University of Toronto, Janssen to research new treatments for major brain disorders
By PBR Staff Writer
The University of Toronto has entered into three-year strategic open innovation agreement with Janssen facilitated by the Johnson & Johnson Innovation center of California to research new treatments for major brain disorders.
Contract Research & Services > Contract Research > News
FeF Chemicals - Insulin Human and Benzalkonium Chloride Products
FeF Chemicals is a Novo Nordisk company that specialises in the supply of ingredients for the biopharmaceutical and pharmaceutical industries, such as insulin human for cell culture media and cGMP manufactured quaternary ammonium compounds (usually referred to as quats) such as benzalkonium chloride, cetrimide and cetrimonium bromide.
Contract Research & Services > Contract Research > Suppliers
Q&A: Rodeina Challand, Executive Director Biosimilar Development on the Naming of Biosimilars - the INN Debate
With the publication of the WHO draft proposal for the naming of biologics, what is the potential impact on the business of biosimilars?
Contract Research & Services > Contract Research > Press Releases
View all Contract Research news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250